NCT06416267 · NOT YET RECRUITING
Risk and Clinical Consequences of Low Count Monoclonal B-cell Lymphocytosis (LC MBL)
This study looks at a common blood condition called low count monoclonal B-cell lymphocytosis, which can precede a type of blood cancer. Researchers will study immune markers, genetics, and health outcomes in Jewish and Arab adults over 40 in Israel. No drug or treatment is being tested. The phase is not specified, and details are limited so far.
You may qualify if
- Individuals over the age pf 40
You're excluded if
- Individuals with lymphoproliferative disorder
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2024-05-16